| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Hematology Research Laboratory, Department of Medicine, and The Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire
Abstract
Although it has been clearly established that glucocorticoids inhibit mitogen- or antigen-induced lymphocyte proliferation, the mechanism underlying this effect has remained ill-defined. Recently, it has become evident that T cell proliferation is mediated by a soluble T cell growth factor (TCGF) released by mitogen/antigen stimulated T cells. Therefore it seemed probable that the inhibitory effects of glucocorticoids were manifested either at the level of TCGF production or at the level of the activated T lymphocyte. We found that differentiated cytolytic T lymphocytes harvested from TCGF-dependent long-term culture were only mildly sensitive to inhibitory effects (25 to 30% inhibition) of glucocorticoids as measured by decreased cellular proliferation and the incorporation of tritiated thymidine. The degree of inhibition observed was most probably mediated through glucocorticoid receptors in that the half maximal inhibitory glucocorticoid concentration correlated with half-maximal glucocorticoid receptor saturation. In contrast, we found that mitogen-induced TCGF production and T cell proliferation were completely inhibited by pharmacologic concentrations of dexamethasone (10-6 M). Finally, the TCGF supplementation of mitogen-stimulated cultures treated with maximal inhibitory concentrations of dexamethasone resulted in complete amelioration of glucocorticoid suppression. These results indicate that a major mechanism of glucocorticoid-mediated immunosuppression may occur at the level of the TCGF-producing cell, resulting in the control of clonal expansion of activated T cells via inhibition of TCGF production.
Footnotes
1 This work was supported in part by National Cancer Institute Grants CA-17643-04, CA-17323-04, and CA-23108, and Contract NO1-CB-74141, and by a grant from the National Leukemia Association, Inc.
2 Fellow of the Leukemia Society of America.
3 To whom correspondence should be addressed.
This article has been cited by other articles:
|
|
 |
|
  R. W. J. Lee, T. J. Creed, L. P. Schewitz, P. V. Newcomb, L. B. Nicholson, A. D. Dick, and C. M. Dayan CD4+CD25int T Cells in Inflammatory Diseases Refractory to Treatment with Glucocorticoids J. Immunol., December 1, 2007; 179(11): 7941 - 7948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D'Elia, J. Patenaude, C. Hamelin, D. R. Garrel, and J. Bernier Corticosterone binding globulin regulation and thymus changes after thermal injury in mice Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E852 - E860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sterzer, G. J. Wiegers, and J. M. H. M. Reul Long-Term in Vivo Administration of Glucocorticoid Hormones Attenuates Their Capacity to Accelerate in Vitro Proliferation of Rat Splenic T Cells Endocrinology, August 1, 2004; 145(8): 3630 - 3638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stoeck, R. Riedel, G. Hochhaus, D. Hafner, J. M. Masso, B. Schmidt, A. Hatzelmann, D. Marx, and D. S. Bundschuh In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 249 - 258. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. J. Green, S. J. Croaker, and D. G. Rowbottom Carbohydrate supplementation and exercise-induced changes in T-lymphocyte function J Appl Physiol, September 1, 2003; 95(3): 1216 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Tyler and K. A. Cummins Effect of Dietary Ascorbyl-2-Phosphate on Immune Function after Transport to a Feeding Facility J Dairy Sci, February 1, 2003; 86(2): 622 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Motzer, M. Jarrett, M. M. Heitkemper, and J. Tsuji Natural Killer Cell Function and Psychological Distress in Women with and without Irritable Bowel Syndrome Biol Res Nurs, July 1, 2002; 4(1): 31 - 42. [Abstract] [PDF]
|
|
|
|
 |
|
 W W Chatham and R P Kimberly Treatment of lupus with corticosteroids Lupus, March 1, 2001; 10(3): 140 - 147. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Kavelaars, W. Kuis, L. Knook, G. Sinnema, and C. J. Heijnen Disturbed Neuroendocrine-Immune Interactions in Chronic Fatigue Syndrome J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 692 - 696. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Milner, S. C. Kent, T. A. Ashley, S. B. Wilson, J. L. Strominger, and D. A. Hafler Differential Responses of Invariant V{alpha}24J{alpha}Q T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone J. Immunol., September 1, 1999; 163(5): 2522 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Goldman, S. E. Miles, H. E. Rudloff, K. H. Palkowetz, and F. C. Schmalstieg Jr. Immunodeficiency Due to a Unique Protracted Developmental Delay in the B-Cell Lineage Clin. Vaccine Immunol., March 1, 1999; 6(2): 161 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wargnier, C. Lafaurie, S. Legros-Maida, J.-F. Bourge, F. Sigaux, M. Sasportes, and P. Paul Down-regulation of Human Granzyme B Expression by Glucocorticoids. DEXAMETHASONE INHIBITS BINDING TO THE Ikaros AND AP-1 REGULATORY ELEMENTS OF THE GRANZYME B PROMOTER J. Biol. Chem., December 25, 1998; 273(52): 35326 - 35331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. DeKruyff, Y. Fang, and D. T. Umetsu Corticosteroids Enhance the Capacity of Macrophages to Induce Th2 Cytokine Synthesis in CD4+ Lymphocytes by Inhibiting IL-12 Production J. Immunol., March 1, 1998; 160(5): 2231 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Norbiato, M. Bevilacqua, T. Vago, A. Taddei, and M. Clerici Glucocorticoids and the Immune Function in the Human Immunodeficiency Virus Infection: A Study in Hypercortisolemic and Cortisol-Resistant Patients J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3260 - 3263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mori, O. Kaminuma, M. Suko, S. Inoue, T. Ohmura, A. Hoshino, Y. Asakura, K. Miyazawa, T. Yokota, Y. Okumura, et al. Two Distinct Pathways of Interleukin-5 Synthesis in Allergen-Specific Human T-Cell Clones Are Suppressed by Glucocorticoids Blood, April 15, 1997; 89(8): 2891 - 2900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Knowlton Adrenal Insufficiency in the Intensive Care Setting J Intensive Care Med, January 1, 1989; 4(1): 35 - 45. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Smith Interleukin-2: inception, impact, and implications Science, May 27, 1988; 240(4856): 1169 - 1176. [Abstract] [PDF]
|
|
|
|
|
|
M. Lumpkin The regulation of ACTH secretion by IL-1 Science, October 23, 1987; 238(4826): 452 - 454. [PDF]
|
|
|
|
|
|
H Besedovsky, A del Rey, E Sorkin, and C. Dinarello Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones Science, August 8, 1986; 233(4764): 652 - 654. [Abstract] [PDF]
|
|
|
|
|
|
P. R. Mittelstadt and J. D. Ashwell Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ J. Biol. Chem., July 27, 2001; 276(31): 29603 - 29610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bianchi, C. Meng, and L. B. Ivashkiv Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids PNAS, August 15, 2000; 97(17): 9573 - 9578. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
